Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
boston blog main
boston top stories
national top stories
san diego blog main
boston
clinical trials
san diego top stories
san francisco blog main
startups
vc
deals
gene therapy
new york blog main
san diego
san francisco top stories
science
third rock ventures
1964 births
abide therapeutics
acetylon pharmaceuticals
allergan
ally bridge group
alnylam
amazon.com
amazon.com people
ambys medicines
american adoptees
american billionaires
american chief executives
american computer businesspeople
american libertarians
american technology company founders
amylin pharmaceuticals
archive
arena pharmaceuticals
artie suckow
astellas pharma
What
diseases
10
×
medicines
10
×
new
company
developing
treat
announced
bio
biotech
deliver
drug
genetic
help
ipo
long
million
need
raises
rna
startup
therapeutics
way
years
abide
activated
addition
advance
age
aging
ago
aiming
alltrna
ambys
analysis
anti
appointed
assess
based
betting
bezos
Language
unset
unknown
Current search:
diseases
×
medicines
×
@wired.com
7 months ago
Everything You Need to Know About Getting Your Genome Sequenced
@techcrunch.com
2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@slashgear.com
4 years ago
Laser activated microbots can deliver meds to specific body parts
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@techcrunch.com
7 years ago
Jeff Bezos, Mayo Clinic back anti-aging startup Unity Biotechnology for $116 million